Europe Molecular Diagnostics Market to Reach US$4.2 bn by 2023, Adoption of Next Generation Sequencing Technologies Rapidly Rise

According to a new market report published by Transparency Market Research “Molecular Diagnostics Market – Europe Industry Analysis, Size, Share, Growth, Trends and Forecast 2015 – 2023” the Europe molecular diagnostics market was valued at US$ 1.6 billion in 2014 and is estimated to reach US$ 4.2 billion by 2023 at a CAGR of 11.4% from 2015 to 2023.

Browse the full Molecular Diagnostics Market (By Technology: Polymerase Chain Reaction, Hybridization (ISH and FISH), Mass Spectrometry, Transcription Mediated Amplification (TMA), Next Generation Sequencing, Biochips and Microfluidics, and Others (Nanotechnology and Proteomic); By Application: Oncology, Infectious Disease Testing, Genomics, Blood Screening, Women’s Health, Microbiology, and Prenatal and Newborn Screening) – Europe Industry Analysis, Size, Share, Growth, Trends and Forecast 2015 – 2023 report at https://goo.gl/9M6KcX

Molecular diagnostics aids in early detection of various chronic infectious diseases, cancer, inherited and non-inherited disorders. Growing prevalence of hospital acquired infections and increasing unhealthy lifestyle of the population in Europe is driving the growth of molecular diagnostics market in the region. In addition, technological advancement in the field of molecular techniques, nanotechnology and proteomics is also propelling the growth of molecular diagnostics market in Europe.

The Europe molecular diagnostics market is categorized on the basis of technology: polymerase chain reaction, hybridization (ISH AND FISH), mass spectrometry, transcription mediated amplification (TMA), next generation sequencing, biochips and microfluidics, others which includes nanotechnology and proteomics. The polymerase chain reaction segment dominated the Europe molecular diagnostics market in 2014. Factors such as cost-effectiveness, and acceptance of polymerase chain reaction over various other technologies contributed towards the growth of market segment. The next generation sequencing segment is expected to register the fastest growth during the forecast period due to high-throughput functional genomic research. The next generation sequencing technology finds its application in whole-genome sequencing, targeted resequencing, discovery of transcription factor binding sites, and noncoding RNA expression profiling.

Based on application, the Europe molecular diagnostics market has been segmented into seven types: oncology, infectious disease testing, genomics, blood screening, women’s health, microbiology, and prenatal and newborn screening. Infectious disease testing held the largest market share in 2014 due to increasing incidence of chronic infectious diseases in Europe. Furthermore, increasing infections due to environmental pollution, and growing unhealthy lifestyles among the global population also contributed towards the growth of the infectious disease testing market. 

The Europe molecular diagnostics market exhibits intense competition among the existing players. The market is fragmented, characterized by the presence of both established as well as emerging companies. Major players operating in the Europe molecular diagnostics market are F. Hoffmann-La Roche Ltd., Abbott Laboratories, QIAGEN N.V., Hologic, Inc., Cepheid, Inc., Siemens AG, Alere. Inc., BioMerieux, Bio-Rad Laboratories, PerkinElmer, Inc., Thermo Fisher Scientific, Inc., and others.   

The Europe molecular diagnostics market is segmented as given below:

Europe Molecular Diagnostics Market, by Technology

  • Polymerase Chain Reaction
  • Hybridization (ISH and FISH)
  • Mass Spectrometry
  • Transcription Mediated Amplification (TMA)
  • Next Generation Sequencing
  • Biochips and Microfluidics
  • Others (Nanotechnology and Proteomic)

Europe Molecular Diagnostics Market, by Application

  • Oncology
  • Infectious Disease Testing
  • Genomics
  • Blood Screening
  • Women’s Health
  • Microbiology
  • Prenatal and Newborn Screening

Europe Molecular Diagnostics Drugs Market, by Major Region and Countries

  • Northern Europe
    • Ireland
    • Norway
    • Sweden
    • United Kingdom
    • Rest of Northern Europe (Denmark, Finland)
  • Eastern Europe
    • Ukraine
    • Poland
    • Czech Republic
    • Russia
    • Rest of Eastern Europe (Hungary, Romania)
  • Western Europe
    • France
    • Germany
    • Austria
    • Rest of Western Europe (Netherlands, Belgium)
  • Southern Europe
    • Italy
    • Spain
    • Portugal
    • Rest of Southern Europe (Greece, Switzerland)
  • Rest of Europe

Download Exclusive Brochure of This Report : https://goo.gl/GCxFxD

About Us

Transparency Market Research (TMR) is a market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants, use proprietary data sources and various tools and techniques to gather, and analyze information. Our business offerings represent the latest and the most reliable information indispensable for businesses to sustain a competitive edge.

Each TMR syndicated research report covers a different sector – such as pharmaceuticals, chemicals, energy, food & beverages, semiconductors, med-devices, consumer goods and technology. These reports provide in-depth analysis and deep segmentation to possible micro levels. With wider scope and stratified research methodology, TMR’s syndicated reports strive to provide clients to serve their overall research requirement.

US Office Contact

90 State Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA – Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com
Website: www.transparencymarketresearch.com

Designed by CyFocus.com
Powered by CyFocus.net
%d bloggers like this: